CAS 1403744-56-8

Begelomab

CAS: 1403744-56-8

Begelomab (SAND-26) is a mouse-derived monoclonal antibody targeting DPP-4/CD26. Begelomab can be used to study severe refractory inflammatory myopathies.

Reinheit: 97.8% (SDS-PAGE); 98.3% (SEC-HPLC) - 97.8% (SDS-PAGE); 98.3% (SEC-HPLC)

Farbe und Form: Transparent Liquid

Molekulargewicht: 146.20 kDa (Predicted)

Ref: TM-T76922

Begelomab

CAS: 1403744-56-8

Reinheit: 95%

Ref: IN-DA02AP5R